Neuland Laboratories saw its shares drop 6% after reporting mixed financial results for the third quarter. As of 9:23 AM, the shares were trading 6.04% lower at Rs 13,786.90.
While the company’s revenue showed a modest 1.3% year-on-year growth, reaching ₹398.03 crore compared to ₹392.83 crore, profitability took a hit due to a sharp decline in operating margins.
EBITDA fell by 29% to ₹86.60 crore from ₹121.27 crore in the same period last year, leading to a significant contraction in EBITDA margins from 30.9% to 21.8%. However, net profit saw a 25% jump to ₹101.59 crore, up from ₹81.39 crore, driven by an exceptional item of ₹55.77 crore recorded during the quarter.
Despite the growth in net profit, the sharp drop in EBITDA and margin contraction raised investor concerns, triggering the decline in stock price.
Neuland Laboratories’ stock opened at ₹13,900.00, reaching a high of ₹14,000.00 and a low of ₹13,704.10. The stock’s 52-week high stands at ₹18,100.00, while the 52-week low is ₹5,540.10.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.